SCHEMBL30859967

SCHEMBL30859967

CCOC(=O)Cc1cc(C(F)(F)F)c(=O)n(Cc2ccc(OC)cc2)n1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MAPT P10636 3/20 0.45
KDM4E B2RXH2 2/20 0.45
THRB P10828 2/20 0.45
FPR1 P21462 1/20 0.45
RAB9A P51151 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PTGDR2 Q9Y5Y4 3/20 0.43
NPBWR1 P48145 1/20 0.42
MAPK8 P45983 1/20 0.41
MAPK10 P53779 1/20 0.41
AKR1C3 P42330 1/20 0.40
UCHL1 P09936 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30860074 0.87 PTGDR2 (0.50) PTGDR2NPBWR1AKR1C3
SCHEMBL30860079 0.84 NPBWR1 (0.48) PTGDR2NPBWR1AKR1C3
SCHEMBL30859877 0.81 NPBWR1 (0.46) PTGDR2NPBWR1AKR1C3
SCHEMBL31464912 0.79 NPBWR1 (0.46) NPBWR1AKR1C3
SCHEMBL25225321 0.79 MAPT (0.44) ALDH1A1MAPTKDM4ETHRBFPR1
SCHEMBL24739013 0.79 NPBWR1 (0.52) MAPTNPBWR1
SCHEMBL27165200 0.76 MAPT (0.44) ALDH1A1MAPTKDM4EHSD17B10KMT2A
SCHEMBL24739563 0.76 MAPT (0.35) ALDH1A1MAPTTHRBPTGDR2NPBWR1
SCHEMBL24739469 0.76 MAPT (0.35) ALDH1A1MAPTTHRBPTGDR2NPBWR1
SCHEMBL24739192 0.75 MAPT (0.34) ALDH1A1MAPTTHRBPTGDR2NPBWR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594314-A1 PYRIDAZIN-3(2H)-ONE AND PYRIDIN-2(1H)-ONE PARP INHIBITOR COMPOUNDS Azkarra Therapeutics, Inc. (US) 2025-08-06 EP disclosed
CN-119968364-A Pyridazin-3 (2H) -one and pyridin-2 (1H) -one PARP inhibitor compounds 阿兹卡拉疗法公司 2025-05-09 CN disclosed
WO-2024073133-A1 PYRIDAZIN-3(2H)-ONE AND PYRIDIN-2(1H)-ONE PARP INHIBITOR COMPOUNDS AZKARRA THERAPEUTICS, INC. (US) 2024-04-04 WO disclosed